Free press releases distribution network?

Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Metrics Expands Stability Storage New Storage Part of $18M Expansion Doubling Metrics' Size - New storage space part of $18-million expansion doubling size of Metrics’ facility in 2008
Metrics Expands Stability Storage New Storage Part of $18M Expansion Doubling Metrics' Size

 

PRZOOM - /newswire/ - Raleigh, NC, United States, 2008/04/02 - New storage space part of $18-million expansion doubling size of Metrics’ facility in 2008.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In a move that boosts its capacity for service by 50 percent, Metrics Inc. is expanding its stability storage.

In its latest expansion, Metrics will offer new environmental specialties (ESI) chambers with redundant mechanical systems that will maintain proper environmental conditions, even in the unlikely event that an electrical failure occurs. All environmental chambers are state of the art and will be fully operational and validated by second quarter 2008. The chambers meet International Conference on Harmonization (ICH) and United States Pharmacopia (USP) guidelines.

In addition, for chambers without such redundancy, Metrics will maintain empty back-up chambers pre-set to condition so that client studies can be transferred immediately if necessary.

Finally, the new storage facility is highly secure, with access to the area being strictly limited to authorized personnel only.

“Since we’ve been functioning at capacity at Metrics for some time now, we are pleased we can now provide our clients with the greater stability storage capacity they need,” said Phil Hodges, president.

Headquartered in Greenville, N.C., Metrics is one of the fastest-growing contract pharmaceutical development laboratories in the United States. The company provides quality pharmaceutical formulation, clinical trial material (Phase I through Phase III) and commercial manufacturing, and analytical development/validation services to the pharmaceutical industry.

Metrics is completing an $18-million, 47,000-square-foot facility addition that will nearly double its analytical and manufacturing space. The expansion is taking place at Metrics’ existing 50,000-square-foot cGMP facility registered with and inspected by the FDA.

Not only will Metrics be able to increase production to 1 billion tablets a year (up from the current level of 50 million), but space for microbiology services will increase five-fold. Metrics offers a full menu of microbiological services to support non-sterile solid dosage forms.

Moreover, the Metrics microbiology department routinely performs bacterial endotoxin and particulate matter testing on parenterals. This year, Metrics will bring antibiotic assay and sterility testing online, enhancing its ability to offer full microbiological support of sterile products.

Since its start in 1994, Metrics has grown from four employees to more than 230 employees and experienced double-digit annual revenue growth.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Metrics Expands Stability Storage New Storage Part of $18M Expansion Doubling Metrics' Size

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Karen Stinneford 
919-833-9102 kstinneford[.]sinclair-co.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Sinclair & Co. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow Ltd

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today